Y.D. More Investments’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-40
Closed -$1.12K 468
2025
Q1
$1.12K Buy
+40
New +$1.42K ﹤0.01% 416
2023
Q2
Sell
-1,400
Closed -$215K 344
2023
Q1
$215K Hold
1,400
0.05% 129
2022
Q4
$250K Buy
+1,400
New +$229K 0.06% 146

Other funds holding MRNA

Y.D. More Investments's MRNA Position: Q2 2025 in Review

Y.D. More Investments sold out of Moderna (MRNA) in Q2 2025, closing a stake of 40 shares — an estimated $1.12K sold.

Y.D. More Investments first reported a position in MRNA in Q4 2022 and held it in 3 quarters. The position peaked at $250K in Q4 2022. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • Y.D. More Investments reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • Y.D. More Investments sold 40 Moderna shares in Q2 2025, an estimated $1.12K.
  • Y.D. More Investments first reported a position in Moderna in Q4 2022 and held it in 3 quarters.
  • Y.D. More Investments's Moderna position peaked at $250K in Q4 2022.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on Y.D. More Investments's 13F filing for Q2 2025, filed 11 Aug 2025.